Scientists led by Botond Roska at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) have developed MitoCatch, a system that enables targeted delivery of healthy mitochondria to specific cell types affected by disease. This innovation is a major step toward precision mitochondrial therapy.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Gene therapy discovery triggers hope for glaucoma patients

Modulation of tau expression in C57BL/6 mice retinas. Credit: Acta Neuropathologica Communications (2024). DOI: 10.1186/s40478-024-01804-0 The protein tau is essential to the function of cells in the brain and central

Female sex hormones linked to faster progression of eye disease

Microscopic images of retinal sections show photoreceptors, the cells that sense light for vision, marked by a yellow arrow. Seven-month-old female mice (purple border) with retinitis pigmentosa, an inherited blinding

Human vision restored by stem cell replacement in regenerative medicine breakthrough

Fabrication and transplantation of human iCEPSs. Credit: The Lancet (2024). DOI: 10.1016/S0140-6736(24)01764-1 Researchers led by Osaka University in Japan have conducted the first human trial using induced pluripotent stem-cell-derived corneal